( 母液浓度为 40 mg/mL ), 如您需要配置的浓度超过该产品的溶解度,请先与我们客服联系。| 中文名称: | 氟哌啶醇 一键复制产品信息 | ||||
|---|---|---|---|---|---|
| 英文名称: | Haloperidol | ||||
| 别名: | 氟哌丁苯;4-(4-(4-氯苯基)-4-羟基哌啶-1-基)-1-(4-氟苯基)丁-1-酮 Haloperidol | ||||
| CAS No: | 52-86-8 | 分子式: | C21H23ClFNO2 | 分子量: | 375.86 |
| CAS No: | 52-86-8 | ||||
| 分子式: | C21H23ClFNO2 | ||||
| 分子量: | 375.86 | ||||
| EINEC: | 200-155-6 | ||||
| EINEC: | 200-155-6 | ||||
基本信息
|
产品编号: |
H10402 |
||||
|
产品名称: |
Haloperidol |
||||
|
CAS: |
52-86-8 |
储存条件 |
粉末 |
-20℃ |
四年 |
|
|
|
||||
|
分子式: |
溶于液体 |
-80℃ |
6个月 |
||
|
分子量: |
375.86 |
-20℃ |
1个月 |
||
|
化学名: |
4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl) |
||||
|
Solubility (25°C): |
|||||
|
体外:
|
DMSO |
75mg/mL (199.54mM) |
|||
|
Ethanol |
25mg/mL (66.51mM) |
||||
|
Water |
Insoluble |
||||
|
体内(现配现用): |
10% DMSO+corn oil |
5mg/mL |
|||
|
<1mg/ml表示微溶或不溶。 |
|||||
|
普西唐提供的所有化合物浓度为内部测试所得,实际溶液度可能与公布值有所偏差,属于正常的批间细微差异现象。 |
|||||
|
请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;⼀旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 |
|||||
制备储备液
|
浓度
溶液体积 质量 |
1mg |
5mg |
10mg |
|
1mM |
2.6606mL |
13.3028mL |
26.6057mL |
|
5mM |
0.5321mL |
2.6606mL |
5.3211mL |
|
10mM |
0.2661mL |
1.3303mL |
2.6606mL |
|
50mM |
0.0532mL |
0.2661mL |
0.5321mL |
生物活性
|
产品描述 |
一种有效的 dopamine D2 receptor 拮抗剂。 |
|
靶点 |
Dopamine Receptor |
|
体内研究 |
Haloperidol (1mg) intra-arterially attenuates the dopamine-induced pancreatic secretion.Haloperidol (3mg) completely inhibits the action of 10μg of dopamine in the pancreas of the dogs.Haloperidol (10mg/kg) as well as chlorpromazine (CPZ,15mg/kg) blocks mescaline-induced altered behavior within 7 to 10 minutes when injected into the mice 45 minutes after 50mg/kg (2µc) of mescaline. Haloperidol has no effect on mescaline disappearance. |
推荐实验方法(仅供参考)
|
动物实验: |
|
|
Male albino mice of Swiss-Webster strain (33-36g) are used,and all substances are given by i.p.injection in a volume of 0.5mL.CPZ,haloperidoi and mescaline are all in time form of timeir imydrochlorides and the dose solutions are prepared at concentrations of 1.0,0.66 and 3.3mg/mL of 0.9% saline,respectively.The doses are:CPZ,15mg/kg;haloperidol,10mg/kg;mescaline,50mg/kg.Mice are pretreated with either CPZ or haloperidol 30 minutes before administration of mescaline.In some instances CPZ is injected 45 minutes after mescaline.Time animals are hmoused individually in a plexiglas cage and the gross behavior and locomotor activity.At selected intervals after mescaline, groups of mice are sacrificed by decapitation.Plasma is separated and stored at -20℃.The brain,liver,kidney,lung,spleen and heart are frozen on dry ice and stored at -20℃ for 18 to 20 hours before they are used for assays. |
|
本计算器可帮助您计算出特定溶液中溶质的质量、溶液浓度和体积之间的关系,公式为:
质量 (g) = 浓度 (mol/L) x 体积 (L) x 分子量 (g/mol)
摩尔浓度计算公式
用本工具协助配置特定浓度的溶液,使用的计算公式为:
开始浓度 x 开始体积 = 最终浓度 x 最终体积
稀释公式
稀释公式一般简略地表示为:C1V1 = C2V2 ( 输入 输出 )
母液,添加 300 μLPEG300
混匀澄清,再加 50μLTween80, 混匀澄清,再加 600μLSaline/PBS/ddH2O
混匀澄清方案所需的各种助溶剂如: DMSO , PEG300 / PEG400 , Tween 80 , SBE-β-CD , 玉米油 等, 均可点击跳转或在网站搜索购买。
计算结果:
工作液浓度: mg/ml;
DMSO母液配制方法: mg 药物溶于 μL DMSO溶液(母液浓度 mg/mL,
体内配方配制方法:取 μL DMSO母液,加入 μL PEG300,混匀澄清后加入μL Tween 80,混匀澄清后加入 μL Saline/PBS/ddH2O,混匀澄清。
1. 首先保证母液是澄清的;
2.
一定要按照顺序依次将溶剂加入,进行下一步操作之前必须保证上一步操作得到的是澄清的溶液,可采用涡旋、超声或水浴加热等物理方法助溶。
.png)
